Sodium-Glucose Co-Transporter 2 Inhibitors as a Powerful Cardioprotective and Renoprotective Tool: Overview of Clinical Trials and Mechanisms
Sodium-glucose co-transporter 2 (SGLT2) inhibitors have been linked to beneficial effects on cardiovascular risk factors, blood pressure, body weight, and lipid profile, according to a substantial body of literature. Significant cardiac and renal benefits with the use of SGLT2 inhibitors have been s...
Main Authors: | Andrej Belančić, Sanja Klobučar |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Diabetology |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-4540/4/3/22 |
Similar Items
-
Tyrosol and Hydroxytyrosol: Their Role in Cardioprotection
by: Cezary Guzowski, et al.
Published: (2024-02-01) -
In vivo Antidiabetic Activity Evaluation of Aqueous and 80% Methanolic Extracts of Leaves of Thymus schimperi (Lamiaceae) in Alloxan-induced Diabetic Mice
by: Melesie Taye G, et al.
Published: (2020-09-01) -
A randomised control trial of 5-aminolevulinic acid in combination with sodium ferrous citrate to enhance cardioprotection in adults undergoing cardiac surgery (TALEN)
by: Kingwill, AC
Published: (2024) -
Antidiabetic medicinal plants from the Chenopodiaceae family: a comprehensive overview
by: Nezar Cherrada, et al.
Published: (2024-12-01) -
Modern antihyperglycemic therapy: safety and efficacy of glimepiride
by: Lyudmila Alexandrovna Ruyatkina, et al.
Published: (2012-06-01)